Myomancy ADHD, Dyslexia and Autism

Shire Falls on Full-Year Forecast for Vyvanse Sales (Update2) - Bloomberg


RTT News
Shire Falls on Full-Year Forecast for Vyvanse Sales (Update2)
Bloomberg - 22 hours ago
The Basingstoke, England-based drugmaker, which reported first- quarter earnings today, has a sales goal of $350 million to $450 million for Vyvanse. …
ROUNDUP Shire Q1 in line, share volatility caused by Vyvanse … Forbes
Shire's Vyvanse forecast disappoints International Herald Tribune
Shire Profit Up 14%, Sees Low-end Vyvanse Sales FOXBusiness
Therapeutics Daily (subscription) (press release) - Bloomberg
all 78 news articles

Find Out More:

Books:

April 26th, 2008
Vyvanse

Leave a Reply

*Required

Truncated Domes

ADHD Boarding Schools

Pharmaceuticals GMP Procedures

Moving

Child Development

Autism Nutrition and Chelation

Natural ADHD Treatments

Golfshop



Discuss the topics raised by this article on the Myomancy Forum.

Archives


7418 posts since May 2004

Google Search

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

Myomancy Treatment Database

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner: